Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

Fabrice Barlési; R. Gervais; H. Léna; J. Hureaux; H. Bérard; D. Paillotin; S. Bota; I. Monnet; Abdesslam Chajara; G. Robinet

doi:10.1093/annonc/mdr003

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

著者: Fabrice Barlési, R. Gervais, H. Léna, J. Hureaux, H. Bérard, D. Paillotin, S. Bota, I. Monnet, Abdesslam Chajara, G. Robinet - Annals of Oncology 2011 被引用: 245

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01) | Litlas